Low Dose MT-1303

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
97	潰瘍性大腸炎	1

97. 潰瘍性大腸炎

臨床試験数 : 2,630 / 薬物数 : 1,459 - (DrugBank : 265) / 標的遺伝子数 : 144 - 標的パスウェイ数 : 202

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04857112 (ClinicalTrials.gov)	September 29, 2021	19/4/2021	Study Evaluating Efficacy and Safety of Amiselimod (MT-1303) in Mild to Moderate Ulcerative Colitis	A Phase 2, Randomized, Double-Blinded, Placebo Controlled, Parallel Group Study Evaluating the Effic ...	Ulcerative Colitis	Drug: Low Dose MT-1303;Drug: High Dose MT-1303;Drug: Placebo	Bausch Health Americas, Inc.	NULL	Recruiting	18 Years	75 Years	All	336	Phase 2	United States

First Previous1Next Last